GCM
LONA

Gladius Capital Management’s LeonaBio Inc LONA Stock Holding History

Gladius Capital Management’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-853
Closed -$21.3K – 367
2023
Q1 		$21.3K Sell
853
-327
-28% -$10.5K ﹤0.01% 319
2022
Q4 		$37.4K Buy
1,180
+60
+5% +$1.89K ﹤0.01% 241
2022
Q3 		$34K Buy
+1,120
New +$38.7K ﹤0.01% 266

Other funds holding LONA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Gladius Capital Management's LONA Position: Q2 2023 in Review

Gladius Capital Management sold out of LeonaBio Inc (LONA) in Q2 2023, closing a stake of 853 shares — an estimated $21.3K sold.

Gladius Capital Management first reported a position in LONA in Q3 2022 and held it in 3 quarters. The position peaked at $37.4K in Q4 2022. 77 funds tracked by Wall St. Rank hold LONA as of Q2 2023.

  • Gladius Capital Management reported no remaining LeonaBio Inc position as of Q2 2023 after selling out during the quarter.
  • Gladius Capital Management sold 853 LeonaBio Inc shares in Q2 2023, an estimated $21.3K.
  • Gladius Capital Management first reported a position in LeonaBio Inc in Q3 2022 and held it in 3 quarters.
  • Gladius Capital Management's LeonaBio Inc position peaked at $37.4K in Q4 2022.
  • 77 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2023.

Based on Gladius Capital Management's 13F filing for Q2 2023, filed 8 Aug 2023.